Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-002177

Director sold 30,000 shares at $58.66 ($1,759,800)

  • Director acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KUEBLER CHRISTOPHER A Director 2018-01-02 Option exercise +30,000 $14.26 $427,800 70,500 D: show line 1 in the form
KUEBLER CHRISTOPHER A Director 2018-01-02 Sale −30,000 $58.66 $1,759,800 40,500 D: show line 2 in the form
Open-market sales · 30,000 sh · avg $58.66 · $1,759,800

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KUEBLER CHRISTOPHER A Director 2018-01-02 Option exercise · Stock Option −30,000 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…